Neion Bio raises $23M Series A to make proteins from chicken eggsnews2026-06-11T11:00:19+00:00June 11th, 2026|Endpoints News|
Grace Science says FDA bottleneck jeopardizes rare disease therapynews2026-06-09T18:22:35+00:00June 9th, 2026|Endpoints News|
WuXi AppTec added to Pentagon’s list of companies linked to Chinese military news2026-06-09T11:12:47+00:00June 9th, 2026|Endpoints News|
#ADA26: Pfizer monthly shot shows effect on obesity, diabetesnews2026-06-06T13:00:02+00:00June 6th, 2026|Endpoints News|
Mammalian hair, roof leaks: Novo Nordisk’s site in Indiana under FDA scrutiny once againnews2026-06-04T16:14:22+00:00June 4th, 2026|Endpoints News|
Hikma to funnel $267M to Ohio; Cingulate gets CRL for ADHD drug news2026-06-04T15:42:37+00:00June 4th, 2026|Endpoints News|
Lilly, Boehringer retrench in Germany on proposed health spending cutsnews2026-06-04T15:13:21+00:00June 4th, 2026|Endpoints News|
Niowave’s $75M radioisotope facility; CordenPharma to buy AmbioPharmnews2026-05-28T13:54:21+00:00May 28th, 2026|Endpoints News|
Charles River CEO says it likely won’t be the last manufacturer to break away from cell and gene therapynews2026-05-28T13:38:47+00:00May 28th, 2026|Endpoints News|
WuXi Bio signs deal to manufacture Viridian’s thyroid eye disease drugnews2026-05-27T13:55:31+00:00May 27th, 2026|Endpoints News|
